Abstract: Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.

Abstract: Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.

Abstract: Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.

Abstract: Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.

Abstract: Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.

Abstract: Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.

Abstract: Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.

Abstract: Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.

Abstract: A pharmaceutical composition for treatment of chronic pain includes lidocaine, glucose, sodium chloride and sodium bicarbonate. The pharmaceutical composition could be applied for treatment of chronic pains in local position such as soft tissue, muscle tendon, synovial bursa.

Abstract: A hierarchical data server provides a query and storage system for hierarchical data with three interfaces that are, data interface for accepting hierarchical data, query interface for accepting a query, and result interface for returning output of the query. The system models hierarchical data with one data object called data vine and one data structure type called data vine list. A data vine includes a name, a property list, and a child list. A data vine list is an ordered list of data vines. A data vine is recursively defined with its child list as a data vine list. The system introduces five basic operators, cast, restrict, unique, sort, and traverse. Each operator acts on one data vine list and returns another data vine list. A property list in a data vine is unordered with set operations implemented, which include default operation, update operation, elimination operation, replacement operation, and intersection operation.

Abstract: A hierarchical data server provides a query and storage system for hierarchical data with three interfaces that are, data interface for accepting hierarchical data, query interface for accepting a query, and result interface for returning output of the query. The system models hierarchical data with one data object called data vine and one data structure type called data vine list. A data vine includes a name, a property list, and a child list. A data vine list is an ordered list of data vines. A data vine is recursively defined with its child list as a data vine list. The system introduces five basic operators, cast, restrict, unique, sort, and traverse. Each operator acts on one data vine list and returns another data vine list. A property list in a data vine is unordered with set operations implemented, which include default operation, update operation, elimination operation, replacement operation, and intersection operation.

Abstract: The present invention relates to a compound of the Formula I or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3A, R3B, R4, R5, X, m, and n are as defined herein. Such novel benzamidazole derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to a compound of the Formula I or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3A, R3B, R4, R5, X, m, and n are as defined herein. Such novel benzamidazole derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to a compound of the Formula I or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3A, R3B, R4, R5, X, m, and n are as defined herein. Such novel benzamidazole derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to a compound of the formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, A, X, n, and are as defined herein. Such novel benzamidazole derivatives are useful in trv treatment of abnormal cell growth, such as cancer, in mammals. This invention ate relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing sue compounds.

Abstract: The present invention relates to a compound of the Formula I or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3A, R3B, R4, R5, X, m, and n are as defined herein. Such novel benzamidazole derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.

Abstract: P++ software that provides a Prolog language data storing and processing method, includes making a plurality of different application programs, introduces two structure types into arguments of clauses, implements these two structure types in predicate inputting, memory storing, processing through unification and back tracking, and outputting for each query. The first structure type is hierarchically defined and recursively processed. Its member can be a variable, a data term, or of any other structure type except itself. Its variable child member can be substituted by one of this structure type making a result in the same structure type with different length. The second structure type is recursively defined and processed. Its member can be a variable, a data term, or of any structure type including itself. It has fixed number of members. With these two structure types, addition and multiplication are extended to multi-dimensional space operations.